CY1111533T1 - PHARMACEUTICAL AND / OR COSMETIC PREPARATION CONTAINING AN ORGANIC SILOXANE AND A PHOSPHOLIPID - Google Patents

PHARMACEUTICAL AND / OR COSMETIC PREPARATION CONTAINING AN ORGANIC SILOXANE AND A PHOSPHOLIPID

Info

Publication number
CY1111533T1
CY1111533T1 CY20111100138T CY111100138T CY1111533T1 CY 1111533 T1 CY1111533 T1 CY 1111533T1 CY 20111100138 T CY20111100138 T CY 20111100138T CY 111100138 T CY111100138 T CY 111100138T CY 1111533 T1 CY1111533 T1 CY 1111533T1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical
phospholipid
preparation containing
cosmetic preparation
organic siloxane
Prior art date
Application number
CY20111100138T
Other languages
Greek (el)
Inventor
Ralf Piotrowiak
Bernd G Seigfried
Original Assignee
Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh filed Critical Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh
Publication of CY1111533T1 publication Critical patent/CY1111533T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Abstract

Use of phospholipid in a pharmaceutical and/or cosmetic composition for use in humans, animals or plants, comprising: (i) a pharmaceutical and/or cosmetic active ingredient; and (ii) organosilicon compounds based on oligomeric and/or polymeric diorganosiloxanes, is new. Pharmaceutical and/or cosmetic composition for use in humans, animals or plants, comprises: (i) at least a pharmaceutical and/or cosmetic active ingredient; and (ii) organosilicon compounds based on oligomeric and/or polymeric diorganosiloxanes. ACTIVITY : Virucide; Fungicide; Antibacterial; Dermatological; Neurological; Antibiotic; Analgesic; Antirheumatic; Anticoagulant; Thrombolytic; Antiallergic; Immunosuppressive; Vulnerary; Relaxant; Anticonvulsant; Antiparkinsonian; Antiemetic; Cardiant; Antiasthmatic; Antitussive; Hepatotropic; Cytostatic; Immunomodulatory; Nephrotropic. No biological data given.
CY20111100138T 2000-05-19 2011-02-07 PHARMACEUTICAL AND / OR COSMETIC PREPARATION CONTAINING AN ORGANIC SILOXANE AND A PHOSPHOLIPID CY1111533T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10024413A DE10024413A1 (en) 2000-05-19 2000-05-19 Pharmaceutical and / or cosmetic preparation
EP07004211A EP1818041B1 (en) 2000-05-19 2001-04-14 Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid

Publications (1)

Publication Number Publication Date
CY1111533T1 true CY1111533T1 (en) 2015-08-05

Family

ID=7642554

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20081100100T CY1107159T1 (en) 2000-05-19 2008-01-28 PHARMACEUTICAL AND / OR COSMETIC PREPARATION CONTAINING AN ORGANIC SILOXANE AND A PHOSPHOLIPID
CY20111100138T CY1111533T1 (en) 2000-05-19 2011-02-07 PHARMACEUTICAL AND / OR COSMETIC PREPARATION CONTAINING AN ORGANIC SILOXANE AND A PHOSPHOLIPID

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20081100100T CY1107159T1 (en) 2000-05-19 2008-01-28 PHARMACEUTICAL AND / OR COSMETIC PREPARATION CONTAINING AN ORGANIC SILOXANE AND A PHOSPHOLIPID

Country Status (12)

Country Link
US (1) US20030170194A1 (en)
EP (2) EP1818041B1 (en)
JP (1) JP2003533491A (en)
AT (2) ATE487495T1 (en)
AU (1) AU2001273839A1 (en)
CY (2) CY1107159T1 (en)
DE (3) DE10024413A1 (en)
DK (2) DK1818041T3 (en)
ES (2) ES2296758T3 (en)
PT (2) PT1818041E (en)
SI (1) SI1282446T1 (en)
WO (1) WO2001087344A1 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10251963A1 (en) * 2002-11-08 2004-05-19 Lts Lohmann Therapie-Systeme Ag Wafer-form transmucosal dosage form, comprising solution of active agent, e.g. for combating drug abuse, in phosphatidyl choline fraction, providing both rapid and constant release via the oral cavity
FR2856301B1 (en) * 2003-06-23 2007-08-03 Galderma Res & Dev SPRAY COMPOSITION COMPRISING A PHARMACEUTICAL ACTIVE, AT LEAST ONE VOLATILE SILICONE AND A NON-VOLATILE NON-POLAR PHASE
FR2867682B1 (en) * 2004-03-22 2009-06-05 Galderma Res & Dev ANHYDROUS PHARMACEUTICAL COMPOSITION COMPRISING A SILICONE AGENT AND A SOLUBILIZED ACTIVE INGREDIENT.
JP2008502646A (en) * 2004-06-17 2008-01-31 ガルデルマ・ソシエテ・アノニム Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase, and an oily phase
FR2871697B1 (en) * 2004-06-17 2007-06-29 Galderma Sa SPRAY COMPOSITION COMPRISING AN ASSOCIATION OF PHARMACEUTICAL ASSETS, AN ALCOHOLIC PHASE, AT LEAST ONE VOLATILE SILICONE AND A NON-VOLATILE OIL PHASE
FR2871700B1 (en) * 2004-06-17 2006-11-17 Galderma Sa SPRAY COMPOSITION COMPRISING AN ASSOCIATION OF PHARMACEUTICAL ASSETS, AN ALCOHOLIC PHASE, AND AN OILY PHASE
FR2871695B1 (en) 2004-06-17 2008-07-04 Galderma Sa PHARMACEUTICAL COMPOSITION COMPRISING A SILICONE AGENT AND TWO SOLUBILIZED ACTIVE INGREDIENTS
WO2005123092A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof
EP1928415A2 (en) * 2005-08-13 2008-06-11 Collegium Pharmaceutical, Inc. Topical delivery with a carrier fluid
JP5371235B2 (en) * 2006-12-06 2013-12-18 ロート製薬株式会社 Topical skin preparation
EP1972324A1 (en) * 2007-03-21 2008-09-24 Cognis IP Management GmbH Encapsulated liposomes
WO2009084041A2 (en) * 2008-01-01 2009-07-09 Shasun Chemicals And Drugs Limited Pharmaceutical compositions of dexibuprofen
IL191123A0 (en) * 2008-04-28 2009-02-11 Meir Shinitzky Composition comprising phospholipids in combination with ascorbic acid and cosmetic products comprising it
US20110269704A1 (en) * 2009-07-24 2011-11-03 Seigfried Bernd G Method for developing a liquid composition to be applied to the skin as a foam and a composition that can be applied topically
EP2496263B1 (en) * 2009-11-03 2021-12-29 Lipidor AB Lipid layer forming composition for administration onto a surface of a living organism
JP2013510085A (en) * 2009-11-03 2013-03-21 リピドール エービー Composition for promoting wound treatment
ES2564502T3 (en) 2010-03-17 2016-03-23 Novaliq Gmbh Pharmaceutical composition for the treatment of increased intraocular pressure
EP2444063A1 (en) 2010-10-20 2012-04-25 Novaliq GmbH Liquid pharmaceutical compositions for the delivery of active ingredients
US20140073615A1 (en) * 2011-05-02 2014-03-13 Lipidor Ab Treatment of Psoriasis
WO2012150890A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Antibacterial composition
SE1300709A1 (en) * 2013-11-14 2015-05-15 Lipidor Ab Composition and method of topical treatment
CN108283623A (en) * 2011-05-25 2018-07-17 诺瓦利克有限责任公司 Externally-applied medicinal composition based on semifluorinated alkane class
MY166228A (en) 2012-09-12 2018-06-22 Novaliq Gmbh Compositions comprising mixtures of semifluorinated alkanes
PL3488847T3 (en) 2012-09-12 2024-04-08 Novaliq Gmbh Semifluorinated alkane compositions
WO2014178789A1 (en) * 2013-05-03 2014-11-06 Lipidor Ab Topical composition and carrier for administration of pharmaceutical or cosmetic active ingredients
CN112006989A (en) * 2013-11-14 2020-12-01 立普妥公司 Sprayable topical carriers and compositions comprising phosphatidylcholine
EP3242659A4 (en) 2015-01-09 2018-09-12 Chase Pharmaceuticals Corporation Oxybutynin transdermal therapeutic system combination
PT3355990T (en) 2015-09-30 2019-09-11 Novaliq Gmbh Semifluorinated compounds and their compositions
EP3722274B1 (en) 2015-09-30 2023-06-07 Novaliq GmbH 2-perfluorobutyl pentane for ophthalmic administration
AU2017281296B2 (en) 2016-06-23 2021-03-11 Novaliq Gmbh Topical administration method
CN109890374A (en) 2016-09-22 2019-06-14 诺瓦利克有限责任公司 For treating the pharmaceutical composition of blear-eye
KR20190057338A (en) 2016-09-23 2019-05-28 노바리크 게엠베하 An ophthalmic composition comprising a cyclosporin
EP3612228B1 (en) 2017-04-21 2023-08-23 Dermaliq Therapeutics, Inc. Iodine compositions
EP3621601A1 (en) 2017-05-12 2020-03-18 Novaliq GmbH Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
JP2020535156A (en) 2017-09-27 2020-12-03 ノバリック ゲーエムベーハー Ophthalmic composition containing latanoprost for use in the treatment of eye diseases
CA3076567A1 (en) 2017-10-04 2019-04-11 Novaliq Gmbh Ophthalmic compositions
WO2019166631A1 (en) 2018-03-02 2019-09-06 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
ES2950878T3 (en) 2018-09-27 2023-10-16 Dermaliq Therapeutics Inc Topical sunscreen formulation
SG11202102820VA (en) 2018-10-12 2021-04-29 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH072631B2 (en) * 1987-03-06 1995-01-18 テルモ株式会社 Gel composition
US4783450A (en) * 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
JPH078333B2 (en) * 1987-12-28 1995-02-01 有限会社野々川商事 Oil-in-water emulsion composition and polyhydric alcohol-in-oil emulsion composition
US5489433A (en) * 1991-01-04 1996-02-06 Safe-Tee Chemical Products Company Environmentally safe insecticide
FR2679446B1 (en) * 1991-07-24 1993-10-29 Oreal METHOD FOR MANUFACTURING A COSMETIC COMPOSITION FOR APPLICATION TO HAIR, COMPOSITION OBTAINED BY THIS PROCESS AND METHOD FOR COSMETIC TREATMENT USING THE SAME.
JPH06135816A (en) * 1992-10-30 1994-05-17 Earth Chem Corp Ltd Cosmetic composition
JPH0823801B2 (en) * 1993-04-26 1996-03-06 日本電気株式会社 Disk controller
FR2709131B1 (en) * 1993-08-18 1995-11-10 Cilag Laboratoire Device for dispensing a therapeutic or cosmetic substance, the inert vehicle of which is a volatile polydiorganosiloxane, and composition intended for use in the device.
US5556280A (en) * 1994-05-31 1996-09-17 Pelak; Mark S. Method and apparatus for appliance mounting
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
DE19641259A1 (en) * 1996-10-07 1998-04-16 Kade Pharma Fab Gmbh Medicines based on diclofenac
FR2761912B1 (en) * 1997-04-14 1999-07-02 Capsulis PROCESS FOR ADHERING A PRODUCT TO A SURFACE
DE19804837A1 (en) * 1998-01-29 1999-08-05 Coty Bv Cosmetic product for regeneration and stimulation of skin cells
FR2777179A1 (en) 1998-04-09 1999-10-15 Lvmh Rech Cosmetic and dermatological composition with non-greasy feel and useful as carrier
FR2777181A1 (en) * 1998-04-10 1999-10-15 Lvmh Rech Water-in-oil cosmetic composition without greasy feel and useful as carrier
BE1011899A6 (en) * 1998-04-30 2000-02-01 Ucb Sa PHARMACEUTICAL USE gelling.
DE19826503A1 (en) * 1998-06-13 1999-12-16 Beiersdorf Ag Cosmetic and dermatological preparations containing chitosan and phospholipids
IT1313595B1 (en) * 1999-08-03 2002-09-09 Giorgio Panin SPRAY DISPENSING DEVICE OF A COMPOSITION FOR TOPICAL APPLICATION INCLUDING VITAMIN AND ESSENTIAL FATTY ACIDS.

Also Published As

Publication number Publication date
EP1282446B1 (en) 2007-12-05
DE10024413A1 (en) 2001-12-06
DE50115705D1 (en) 2010-12-23
PT1818041E (en) 2010-12-28
DE50113348D1 (en) 2008-01-17
JP2003533491A (en) 2003-11-11
WO2001087344A1 (en) 2001-11-22
ATE487495T1 (en) 2010-11-15
ES2296758T3 (en) 2008-05-01
EP1818041A2 (en) 2007-08-15
SI1282446T1 (en) 2008-04-30
EP1818041A3 (en) 2007-09-19
PT1282446E (en) 2007-12-21
DK1282446T3 (en) 2008-01-02
EP1818041B1 (en) 2010-11-10
ATE380036T1 (en) 2007-12-15
ES2352222T3 (en) 2011-02-16
CY1107159T1 (en) 2012-10-24
AU2001273839A1 (en) 2001-11-26
DK1818041T3 (en) 2011-02-28
US20030170194A1 (en) 2003-09-11
EP1282446A1 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
CY1111533T1 (en) PHARMACEUTICAL AND / OR COSMETIC PREPARATION CONTAINING AN ORGANIC SILOXANE AND A PHOSPHOLIPID
DE69530926D1 (en) AGENTS FOR PROMOTING HAIR GROWTH
NO20101190L (en) Use of buprenorphine in the manufacture of a medicament
DE60136068D1 (en) MEDICAL PRODUCT PACKAGING FOR BACTERIAL DISPOSAL THERAPY
DE60031396D1 (en) PREPARATION FOR THE TREATMENT OF A NEUROLOGICAL DISEASE
IT1318430B1 (en) DEVICE FOR PASSIVE HUMIDIFICATION OF TRACHEOSTOMIZED OR INTUBATED PATIENTS.
ES2196092T3 (en) LIPOSOMIC ANTIBACTERIAL COMPOSITION, OF LOW RIGIDITY.
NO951055D0 (en) Galenic forms of prolonged release of alfuzosin hydrochloride
ATE173627T1 (en) MEDICAL COMPOSITION
TR199900661T2 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
ES2177849T3 (en) PHARMACEUTICAL PREPARATION, CONTAINING 2-PHENYL-1,2-BENZOISOSELENAZOL-3 (2H) -ONA, FOR THE TREATMENT OF ALZHEIMER'S DISEASE.
BR0015722A (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
TR199800801T2 (en) Treatment of traumatic brain injuries.
TR199901887T2 (en) The carbapenem compound, its use, and the intermediate for this compound.
DE69317058T2 (en) THE ANTIBIOTICS GE 37468 A, B AND C
NO304518B1 (en) Benzimidazoles, their use for the manufacture of a medicament, and pharmaceutical preparations comprising them
BR0112369A (en) Anthelmintics to prevent parasitic infections in humans and animals ii
ATE185680T1 (en) SOLID INSECTICIDAL FORMULATION
CA2122780A1 (en) Use of selegilin in veterinarian medicine
NO307126B1 (en) Use of biologically active ureido derivatives for the manufacture of a medicament for use in the treatment of lentivirus-induced disease
IT1284970B1 (en) PHARMACEUTICAL AND COSMETIC FORMULATIONS WITH ANTI-MICROBIAL ACTIVITY
BR0112366A (en) Anthelmintic agents to prevent parasitic infections in humans and animals iv
TR199701286T1 (en) Esters of carbapenems.
ES1032126Y (en) STERILIZABLE GAME FOR SELF-INJECTION OF DRUGS.
BR0112230A (en) Anthelmintics for the prevention of parasitic infections in humans and animals